期刊文献+

肿瘤标志物在早期肝癌诊断中的价值 被引量:18

The Value of Tumor Markers in the Diagnosis of Early Hepatocellular Carcinoma
下载PDF
导出
摘要 甲胎蛋白(AFP)是最早诊断肝癌的肿瘤标志物,对早期肝癌有较高的诊断价值,但仍有约1/3的早期肝癌AFP阴性。AFP异质体3是AFP中与肝癌相关的组分,高敏检测法对早期肝癌诊断的敏感性高于AFP。高尔基体蛋白73与肿瘤大小及分化程度无关,对AFP阴性的早期肝癌有很高阳性率,且与AFP有互补作用。异常凝血酶原、骨桥蛋白与磷脂酰肌醇蛋白聚糖3在早期肝癌有较高敏感性,且AFP阴性者也有较高阳性率。上述肿瘤标志物联合检测,可提高早期肝癌诊断率。 Alpha-fetoprotein( AFP) is the earliest tumor markers for the diagnosis of hepatocellular carcinoma( HCC) with high diagnostic value of early HCC,but there is still about one-third early HCC patients' AFP are negative. Using highly sensitive method of Lens culinaris agglutinin-reactive fraction of AFP( AFP-L3),which is the submit of AFP associated with HCC,is more sensitive and specific than AFP itself in the diagnosis of HCC in the early stage. In addition,Golgi protein 73 has no correlation with tumor size and differentiation but it plays an complementary role of AFP and has high positive rate in AFP negative early HCC. Moreover,des-gamma-carboxy prothrombin,osteopontin,glypican-3 have not only higher sensitivity in the early HCC,but also higher positive rate of AFP negative HCC. The combination of these tumor markers can significantly improve diagnosis of early HCC.
出处 《医学综述》 2016年第1期76-79,共4页 Medical Recapitulate
基金 深圳市科技研发资金(JCYJ20120831144704366)
关键词 早期肝癌 肿瘤标志物 诊断 Early hepatocellular carcinoma Tumor marker Diagnosis
  • 相关文献

参考文献5

二级参考文献40

共引文献144

同被引文献163

  • 1刘力强,方艳伟,瓮杰慧,邱文娜,耿少梅,焦保华.人脑星形细胞瘤中EphA2-ephrinA1、CD105的表达及与预后的关系[J].肿瘤防治研究,2014,41(6):582-587. 被引量:5
  • 2钟启宝,冯晓辉.EphA2、E-钙黏素在肿瘤中的研究[J].现代生物医学进展,2008,8(1):184-186. 被引量:6
  • 3Hu B,Tian X, Sun J, et al. Evaluation of individual and combined ap- plications of serum biomarkers for diagnosis of hepatocellular carcino- ma:a meta-analysis[ J]. Int J Mol Sci,2013,14(12) :23559-23580.
  • 4Moriya S, Morimoto M, Numata K, et al. Fucosylated Fraction of Alpha- fetoprotein as a Serological Marker of Early Hepatocellular Carcinoma [ J]. Antieancer Res,2013,33 (3) :1013-1321.
  • 5Subwongcharoen S, Leelawat K, Treepongkaruna SA, et al. Serum AFP and AFP-L3 in clinically distinguished hepatocellnlar carcinoma from patients with liver masses [ J ]. J Med Assoc Thai,2011,94 (Suppl 2 ) : $46-$51.
  • 6Gao G,Dong F,Xu X,et al. Diagnostic value of serum Golgi protein 73 for HBV-related primary hepatic carcinoma[ J~. Int J Clin Exp Pathol, 2015,8(9) :11379-85.
  • 7Liang R, Chen XY, Ge LY, et al. Meta-analysis supports the diagnostic value of GP73 in primary liver cancer[ J~. Clin Res Hepatol Gastroen- terol,2015,39 (5) :e71-72.
  • 8Sangro B, Carpanese L, Cianni R, et al. Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Bar- celona clinic liver cancer stages : a European evaluation[J]. Hepatol- ogy,2011,54(3) :868-878.
  • 9Zhao Y, Wang M, Cui C, et al. Significance of combined tests of ser- um golgi glycoprotein 73 and other biomarkers in diagnosis of small primary hepatocellular carcinoma [J]. Cancer Biomark, 2015, 15 (5) :677-683.
  • 10Toyoda H, Kumada T, Tada T, et al. Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein < 20 ng/ml [ J ]. Cancer Sci ,2011,102 (5) : 102541031.

引证文献18

二级引证文献120

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部